Got a ton of DMs from this. What I've learned (US filter):
You can get your peptides from two types of sources:
1. Grey market "research facilities" that buy them from overseas labs (mostly in China) and don't test every batch. They don't require prescriptions and they are cheaper. An independent lab @finnrick_tests randomly tests these providers and grades them.
2. 503a registered pharmacies that make or source through regulated domestic supply chains with USP-grade ingredients. They require a prescription and are more expensive.
I probably got something wrong here, so please correct me. Want to make a decision on a vendor today.

I recently injured my knee, and am hunting for a safe source for BPC-157 and TB-500 peptides to accelerate healing.
My DMs are open for trusted peptide supplier recommendations.

mcclick

Twitter

World Liberty Financial (WLFI) on Thursday released the AgentPay SDK, an open-source toolkit that enables AI agents to autonomously hold, send, and receive funds across Ethereum-compatible blockchains...

World Liberty Financial Launches Toolkit to Let AI Agents Spend USD1

Cryptocurrency asset manager Grayscale has filed an S-1 registration form with the U.S. Securities and Exchange Commission (SEC) for a spot Hyperliquid (HYPE) ETF, Cointelegraph reported. The proposed...

Grayscale files S-1 for spot Hyperliquid ETF

According to ME News, on March 21 (UTC+8), a jury in the U.S. Federal Court in San Francisco delivered its verdict on March 20 in a class-action lawsuit related to Elon Musk's 2022 acquisition of Twitter (now renamed X). The jury found Musk liable for intentionally suppressing Twitter's stock price and misleading investors during the acquisition process, but dismissed charges of orchestrating investor fraud. The trial began on March 2 and focused on two tweets and podcast comments Musk posted in May 2022. One tweet claimed the acquisition was "temporarily suspended" due to an investigation of fake accounts, leading some shareholders to sell their shares at a low price. After nearly four days of deliberation, the nine-person jury ruled that the tweets were misleading, but the podcast comments were not at fault. The verdict indicates that affected shareholders could receive $3-8 per share per day in damages. The plaintiffs' lawyers stated that Musk may have to pay approximately $2.5 billion, with specific details to be determined in the coming weeks. This is a rare defeat for Musk, and his legal team has indicated they will appeal. It is reported that Musk announced his $44 billion acquisition of Twitter in April 2022, later terminated the agreement, and finally completed the transaction at the original price in October. (Source: ME)